James C. Mullen - 14 Jun 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
CEO, Director
Signature
/s/ James C. Mullen
Issuer symbol
EDIT
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 16:20:42 UTC
Previous filing
20 May 2021
Next filing
04 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Award $0 +170,989 $0.000000 170,989 14 Jun 2021 Common Stock 170,989 $45.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the vesting, upon the achievement of a specified organizational milestone, of a portion of a performance-based stock option originally granted on March 2, 2021.